Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Serum VEGF Concentration as an Independent Prognostic Factor for Recurrence After Curative Colon Cancer Surgery. Multicentric Study.

NCT04851054 is registered in ClinicalTrials.gov with Hospital del Mar as lead sponsor.

NCT NCT04851054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04851054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Serum VEGF Concentration as an Independent Prognostic Factor for Recurrence After Curative Colon Cancer Surgery. Multicentric Study.
Lead sponsor
Hospital del Mar
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
December 31, 2021
Enrollment
280 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

angiogenesis, colon cancer, recurrence, surgery, vegf overexpression